Schizophrenia

Question 1

what is schizophrenia?

Answer 1

schizophrenia involves hallucinations and delusions and is a type of psychosis.

Question 2

what are the positive symptoms of schizophrenia?

Answer 2

positive symptoms means excess of normal functions.
delusions: unrealistic beliefs that appear real. they can be paranoid, involve inflated beliefs about the individuals power and importance. the schizophrenic individual will believe that the behaviour and comments of others is directed solely at them.
hallucinations: these can be auditory, visual, olfactory (smelling things) or tactile (something crawling under their skin).

Question 3

what are the negative symptoms of schizophrenia?

Answer 3

loss of normal functions
speech poverty (alogia): poor speech which is thought to reflect slow or blocked thoughts. individuals with this will produce fewer words on a verbal fluency task because they have difficulty spontaneously producing them. speech poverty is also shown through less complex syntax, fewer clauses etc.
avolition: a lack of focused behaviour, instead the individual will appear disinterested in doing things and may simply sit doing nothing for hours sat at a time. they show no initiation or persistence with tasks.

Question 4

what are the social/occupational dysfunctions of schizophrenia?

Answer 4

work, personal, social relationships below the quality of what they were prior to onset.

Question 5

duration of schizophrenia

Answer 5

continuous signs of disturbance for at least six months, including one month of symptoms that meet criterion A. during non-active periods, disturbance may be limited to negative symptoms or two or more symptoms in criterion A.

Question 6

define reliability in schizophrenia

Answer 6

the consistency of the classification system such as the DSM or a measuring instrument to assess particular symptoms of schizophrenia.

Question 7

define validity in schizophrenia

Answer 7

the extent that a diagnosis represents something that is real and distinct from other disorders and the extent that a classification system such as the DSM measures what it claims to.

Question 8

reliability: cultural differences in diagnosis

Answer 8

research suggests that when it comes to diagnosing schizophrenia there are significant variations between culture so culture has an influence on the diagnostic process. Copeland (1971) gave 134 US and 194 British psychiatrists a description of a patient. 69% of the US psychiatrists diagnosed schizophrenia compared to only 2% of British psychiatrists. one of the main characteristics of hearing voices also appears to be influenced by cultural environment. Luhrmann (2015) interviewed 60 adults diagnosed with schizophrenia, 20 each in India, Ghana, and the US. each was asked about what voices they heard, many of the African and Indian subjects reported positive experiences with their voices, describing them as playful and offering advice. no US PPs reported positive experiences, they were more likely to report the voices they heard as violent and hateful. Luhrmann suggests that the harsh, violent voices that are so common in the West may not be an inevitable feature of schizophrenia.

Question 9

Evaluation of reliability

Answer 9

inter-rater reliability and unreliable symptoms: despite claims for increased reliability in the DSM, there is still little evidence that the DSM is routinely used with high reliability by mental health clinicians. Whaley (2001) found inter-rater reliability correlations in the diagnosis of schizophrenia of 0.11. Rosenhan’s (1973) study demonstrated the unreliability of the diagnosis of schizophrenia. ‘normal’ people presented themselves at a psychiatric hospital in the US. they all claimed to hear voices and were subsequently diagnosed and admitted to the hospital. during their stay, no staff recognised that they were not symptomatic.
culture: research has established cultural and racial differences in the diagnosis of schizophrenia. however, the prognosis for members of ethnic minority groups may be actually more positive than for majority group members. the ethnic culture hypothesis predicts that ethnic minority groups experience less distress associated with mental disorders because of the protective characteristics and social structures that exist in most ethnic minority cultures. Brekke and Berrio found evidence to support this hypothesis in a study of 184 individuals diagnosed with schizophrenia or a schizophrenia-spectrum disorder. this sample was drawn from 2 non-white minority groups and a white majority group. they found that non-minority group members were consistently more symptomatic than members of the 2 ethnic minority groups, findings which were supported by the ethnic cultural hypothesis.

Question 10

validity: gender bias in diagnosis

Answer 10

this occurs when the accuracy of diagnosis is dependent on the gender of the individual. the accuracy of the diagnostic judgements can vary for several reasons, including gender-biased diagnostic criteria or clinicians basing their judgements on stereotypical beliefs held about gender. for example, the critics of the DSM diagnostic argue that some diagnostic categories are biased towards pathologising one gender rather than the other. Broverman (1970) found that clinicians in the US equated mentally healthy adult behaviour with mentally healthy male behaviour. As a result, there was a tendency for women to be perceived as less mentally healthy.

Question 11

validity: gender bias in diagnosis evaluation

Answer 11

Loring and Powell (1988) randomly selected 290 male and female psychiatrists to read two case study of patient behaviour. they were then asked to give their judgement on these individuals, using the standard diagnostic criteria. when the patients were described as male or no information was given about their gender, 56% of the psychiatrists gave a diagnosis of schizophrenia. however, when the patients were described as female only, 20% were given a diagnosis of schizophrenia. this gender bias was not as evident among the female psychiatrists, suggesting that diagnosis is influenced not only by the gender of the patient but also the gender of the clinician.

Question 12

validity: symptom overlap

Answer 12

it is believed that identifying positive and negative symptoms of schizophrenia would help to create a more valid diagnosis of schizophrenia. however, many of these symptoms are found in other disorders. Schneider (1959) listed 1st rank symptoms (the most common), which he believed distinguished schizophrenia from other psychotic disorders. these symptoms included delusions of being controlled by external forces, beliefs that the individuals thoughts are being broadcast to others, hearing hallucinatory voices commenting on their thoughts or actions. this made diagnosis more reliable.

Question 13

validity: symptom overlap evaluation

Answer 13

Ellanson and Ross suggest that individuals with Dissociative Identity Disorder (DID) exhibit more schizophrenic symptoms than those diagnosed with schizophrenia, highlighting the complexity of differentiating between these two disorders.
DID is characterized by the presence of distinct identities and memory disruptions, while delusions, hallucinations, and disorganized thinking mark schizophrenia. However, both disorders can share symptoms like dissociation and altered perceptions of reality. The overlap of symptoms can make it challenging to distinguish between DID and schizophrenia, especially when individuals with schizophrenia often display signs that could lead to additional diagnoses, such as mood or personality disorders. This reflects the intricate nature of mental health, where symptoms don’t always align perfectly with a single diagnosis. Therefore, understanding the nuanced differences between these disorders is crucial for accurate diagnosis and treatment, as it allows for more tailored and effective interventions for individuals experiencing these complex conditions

Question 14

validity: co-morbidity

Answer 14

this refers to the extent to which two or more symptoms can co-occur. psychiatric co-morbidities are common among patients with schizophrenia. these include substance abuse, anxiety, and symptoms of depression. for example, Buckley (2009) estimated that co-morbid depression occurs in 50% of patients and 47% of patients also have a lifetime diagnosis of co-morbid substance abuse. schizophrenia and OCD are 2 distinct psychiatric conditions. roughly 1% of the population develop schizophrenia and roughly 2-3% develop OCD. s evidence suggests that the two conditions appear together more than chance would suggest. Swets (2014) conducted a meta-analysis and found that at least 12% of patients with schizophrenia also fulfilled the diagnostic criteria for OCD and about 25% displayed significant obsessive-compulsive symptoms.

Question 15

validity: co-morbidity evaluation

Answer 15

Several studies have examined single co-morbidities with schizophrenia. One example is Weber (2009) who studied just under 6 million hospital discharge records to calculate co-morbidity rates. pPsychiatricand behaviour-related diagnosis accounted for 45% of co-morbidity. However, the study also found evidence of many co-morbid non-psychiatric diagnoses. Many patients with a primary diagnosis of schizophrenia were also diagnosed with medical problems including asthma and type 2 diabetes. It was concluded that the nature of a diagnosis of a psychiatric disorder is that patients tend to receive a lower standard of care, which in turn adversely affects the prognosis for patients with schizophrenia.

Question 16

biological explanations: genetics - general studies

Answer 16

Ripke (2014) carried out a study which combined all previous data from genome-wide studies of schizophrenia. the genetic make-up of 37,000 patients was compared to that of 113,000 control group. 108 separate genetic variations were associated with the increased risk of schizophrenia. genes associated with increased risk included those coding for the functioning of a number of neurotransmitters including dopamine.

Question 17

biological explanations: genetics -family studies

Answer 17

such studies conducted by researchers such as Gottesman (1991) find individuals who have schizophrenia and determine whether biological relatives are similarly affected more often than their non-biological relatives. Such studies have established that schizophrenia is more common among biological relatives of a person with schizophrenia and that the closer the degree of genetic relatedness, the greater the risk. in Gottesman’s study, children with 2 schizophrenic parents had a concordance rate of 46% and children with one schizophrenic parent had a concordance rate of 13%. children with a schizophrenic sibling had a concordance rate of 9%.

Question 18

biological explanations: genetics - evaluation

Answer 18

at face value there seems to be evidence to support the genetic influence on developing schizophrenia, however, it is now accepted that some evidence can be lacking as direct evidence for a genetic link as we now more commonly accept that it could be due to common rearing patterns or environmental stressors that families endure that could lead to the development of the condition, such as expressed emotion. this then opens up the nature vs nurture debate as environmental factors could also increase/decrease the chance of developing schizophrenia, therefore is it solely due to genetics?
89% of those with schizophrenia have no known relative with the disorder. therefore, other biological factors can cause the condition. one explanation looks at the mutation of parental DNA in sperm cells. this mutation can be caused by radiation, poison, or viral infection. a positive correlation was found between paternal age and the risk of schizophrenia. it increased from around 0.7% with fathers under 25, to over 2% in fathers over 50.

Question 19

biological explanations: the dopamine hypothesis

Answer 19

This hypothesis claims that an excess of dopamine (neurotransmitter) in certain regions of the brain is associated with positive symptoms of schizophrenia. Messages from the neurons that transmit dopamine fire too easily or too often which leads to hallucinations and delusions (positive symptoms). People with schizophrenia are believed to have abnormally high numbers of D2 receptors on the receiving neurons, which results in more dopamine binding to the receptors and more neurons firing. The traditional version of the dopamine hypothesis stated that higher dopamine levels occur in the subcortex.
Davis and Kahn proposed a revision of the dopamine hypothesis. They suggested that the positive symptoms of schizophrenia are caused by an excess of dopamine in the subcortical areas of the brain. The negative and cognitive symptoms are thought to come from a deficit of dopamine in regions of the prefrontal cortex. Evidence from the revised hypothesis comes from:
Neural imaging: Patel used PET scans to assess dopamine levels in the individuals and those without. They found lower levels of dopamine in the dorsolateral prefrontal cortex of people with schizophrenia compared to the other individuals.
Animal studies: Wang and Deutsch induced dopamine depletion in rats in their prefrontal cortex. This resulted in them having cognitive impairment. The researchers were able to reverse these symptoms by using olanzapine an atypical psychotic drug thought to benefit the effects of negative symptoms in humans.

Question 20

biological explanations: the dopamine hypothesis evaluation

Answer 20

+ There is significant evidence for the dopamine hypothesis from the use of drugs that successfully altered the levels of dopamine in the hypothesis. Leucht (2013) carried out a meta-analysis of 212 studies that analysed the effectiveness of different antipsychotic drugs compared to a placebo. They found that all the drugs tested were significantly more effective than placebo treatments for both positive and negative symptoms, the drugs normalised the levels of dopamine in the body.
- however, others such as Moncrieff claim that evidence is far from conclusive for the dopamine hypothesis. Stimulants such as cocaine and amphetamines have been shown to induce schizophrenic episodes, but they are known to affect other neurotransmitters other than dopamine. Therefore, other neurotransmitters could lead to schizophrenic symptoms. Also, post-mortem studies have shown negative or inconclusive symptoms for dopamine. It is also known that other sources such as stress and smoking can also be linked to dopamine release which could confound evidence for the role of dopamine in causing schizophrenia. Therefore, it is suggested that the idea that symptoms of schizophrenia are caused by the over-activation of dopamine isn’t supported by strong evidence.

Question 21

biological explanations: neural correlates

Answer 21

These is changes in neuronal events and mechanisms that result in the characteristic symptoms of a behaviour/mental disorder.
Negative symptoms: avolition - motivation involves the anticipation of a reward and the ventral striatum is part of the brain involved in this, so abnormality in the area of the ventral striatum could lead to the development of avolition.
Positive symptoms: it is believed that reduced activity in the superior temporal gyrus and anterior cingulate gyrus is a neural correlate of auditory hallucinations.

Question 22

biological explanations: neural correlates evaluation

Answer 22

negative symptoms: Juckell measured activity levels in the ventral striatum in people with schizophrenia, compared to controls, and found lower levels for schizophrenia. therefore, activity in the ventral striatum is a neural correlate of negative symptoms of schizophrenia.
positive symptoms: Allen scanned the brains of patients experiencing auditory hallucinations whilst they identified recorded speech as their voice or others. they compared the results to a control group. the hallucination group made more mistakes than the control group and had lower activation levels in the 2 specified areas of the brain.

Question 23

drug therapy: typical antipsychotics

Answer 23

conventional/1st gen
used to combat positive symptoms
typical antipsychotics reduce the effects of dopamine and therefore reduce the symptoms of schizophrenia. They are dopamine antagonists; they block the action of dopamine. they bind to the dopamine receptors, particularly the D2 receptors in the mesolimbic dopamine pathway which blocks their action, reducing the stimulation of the dopamine system in the mesolimbic pathway and will eliminate hallucinations and delusions usually within a few days of being on the medication. other symptoms may take longer, up to several weeks before a significant improvement is seen. the effectiveness of these dopamine antagonists in reducing symptoms led to the dopamine hypothesis being developed. Kapur estimates that between 60%-75% of the D2 receptors in the mesolimbic dopamine pathway must be blocked for the drugs to be effective. to achieve this, a similar number of D2 receptors in other areas of the brain must be blocked which can lead to undesirable side effects. this was worked on in the development of atypical antipsychotic medication.

Question 24

drug therapy: atypical anti psychotics

Answer 24

these carry a lower risk of movement problems. they have a beneficial effect on the negative symptoms of schizophrenia and cognitive impairment. these drugs act on the dopamine system by blocking the D2 receptors. however, they only temporarily occupy the D2 receptors, and then rapidly disassociate to allow normal dopamine transmission. it is the rapid dissociation that is thought to be responsible for the lower level risk of movement problems because atypical antipsychotics have little effect on the dopamine systems that control movement.

Question 25

drug therapy: evaluation

Answer 25

Effectiveness of antipsychotic medication: support for how effective these drugs are comes from studies that have compared relapse rates for individuals taking the drug and for those taking a placebo. Leucht carried out a meta-analysis of 65 studies published between 1959 and 2011, involving nearly 6000 patients. All patients had stabilized their symptoms by taking typical or atypical medication. Some of these patients were then taken off their medication and given a placebo, whilst others remained on their medication. Within 12 months, 64% of the patients who had been given the placebo had relapsed, compared to 27% who stayed on their regular medication. Ethical issues: It is believed that if a cost-benefit analysis was conducted, taking into account side effects, deaths, and psychosocial consequences of taking medication, it would probably be negative. In recent years, in the USA, a patient received a large amount of money out of a court settlement for suffering tardive dyskinesia based on the Human Rights Act. It is also widely believed that anti-psychotic drug medication is used in hospitals to calm patients down to make them easier for staff to work with, rather than the drug being given solely for the patient's benefit. This short-term use of psychotics is recommended by the National Institute and Clinical Excellence but many question its ethics.

Question 26

psychological explanations: family dysfunction - double bind theory

Answer 26

Bateson emphasised the importance of communication within a family and suggested there is a link between parents being contradictory towards their child and the development of schizophrenia. the child may receive conflicting messages about the relationship with their parents through different forms of communication e.g. verbal and non-verbal cues. consequently, this makes it difficult for the child to respond to the parent as the messages invalidate each other. therefore, the child will have no opportunity to construct a coherent reality about the relationship, leading to schizophrenic characteristics such as affective flattening and social withdrawal.

Question 27

psychological explanations: family dysfunction - double bind theory evaluation

Answer 27

Berger supports this concept put forward by Bateson, by reporting that schizophrenic individuals did report higher incidences of double-bind statements from their mothers compared to a control group. However, Leim studied patterns of parental communications of families and found no difference between those of a schizophrenic individuals and those who were not schizophrenic. Hall and Levin found no difference in verbal and non-verbal communication between the families of a schizophrenic individual and a control group.

Question 28

psychological explanations: family dysfunction - expressed emotion

Answer 28

This is a form of family communication that is hostile, critical, and emotionally overevolved. The family members speak about the schizophrenic individual in a hostile/critical way, or they will indicate emotional over-involvement or over-concern with the patient and their behaviour. Kuipers found that expressed emotion relatives talk more and listen less and that high levels of expressed emotion are most likely to influence relapse rates, a patient returning to a family high in expressed emotion is 4x more likely to relapse than a patient whose family is low in expressed emotion. This suggests that people with schizophrenia have a lower tolerance for instance environmental stimuli such as emotional comments and interactions with family members. Such negative climates arouses the patient and leads to stress beyond their already impaired coping mechanisms thus triggering symptoms: hallucinations, social withdrawal, paranoia, and low self-esteem.

Question 29

psychological explanations: family dysfunction - expressed emotion evaluation

Answer 29

Not everyone is equally vulnerable to high levels of expressed emotion within a family environment, and individual differences must be considered. Altorfer’s study found that one-quarter of patients showed no psychological response to stressful comments from their relatives. This suggests that how an individual perceives and responds to their family environment plays a crucial role in their vulnerability to relapse. If someone does not perceive highly expressed emotion environments as stressful, they may not be as affected by what is considered an objectively negative or stressful family environment. Therefore, this highlights the importance of accounting for individual differences when evaluating the impact of family dynamics on mental health, as not all patients will respond the same way to high-expressed emotional environments.

Question 30

psychological explanations: dysfunctional thought processing - what is it?

Answer 30

this means people with schizophrenia process information differently from those without the disorder. Frith identified 2 types of dysfunctional thought processing: metarepresentation and central control

Question 31

psychological explanations: dysfunctional thought processing - metarepresentation

Answer 31

this is the cognitive ability to reflect on thoughts and behaviours. it allows us to have insight into our own intentions and goals, as well as interpreting the actions of others. consequently, dysfunction of metarepresentation would disrupt our ability to recognise our own actions and thoughts as being carried out by ourselves, rather than someone else. this could explain hallucinations of voices and delusions like thought insertion. a characteristic of delusional thinking is the person thinking they are a central component in events such as muffled whispers are people talking about them. Aleman (2001) suggests that hallucination-prone individuals find it difficult to distinguish between imagery and sensory-based perception.

Question 32

psychological explanations: dysfunctional thought processing -central control

Answer 32

this is the ability to suppress automatic responses while we perform deliberate actions instead. disorganised speech and thought disorder could result from an inability to suppress automatic thoughts and speech triggered by other thoughts. e.g. people with schizophrenia tend to experience derailment of thoughts and spoken sentences because each word triggers associations and the individual cannot suppress the automatic response to these.

Question 33

psychological explanations: dysfunctional thought processing - evaluation

Answer 33

Cognitive differences between individuals with schizophrenia and healthy controls can be observed through tasks like the Stroop Test. Stirling compared 30 patients with schizophrenia to 18 non-patient controls on a range of cognitive tasks, including the Stroop Test, and found that patients took twice as long to name the ink colors as the control group. This finding supports Frith’s theory, which suggests that individuals with schizophrenia may have impairments in cognitive processes such as attention and information processing. The delay in completing the Stroop Test could reflect difficulties in filtering irrelevant information or focusing attention on relevant stimuli. Therefore, Stirling's study provides further evidence that cognitive deficits are a significant feature of schizophrenia, reinforcing the need for targeted cognitive interventions in treatment. While cognitive theories offer insight into the information processing difficulties seen in schizophrenia, they do not address the origins of these cognitive issues. Cognitive theories explain the proximal causes of schizophrenia, such as impairments in attention and information processing, but fail to account for the distal causes, or the root origins, of these cognitive patterns. This makes cognitive theories somewhat reductionist, as they simplify the complex nature of schizophrenia by focusing only on immediate cognitive processes without considering underlying factors like family dynamics. Bateson, for instance, suggests that contradictory behavior from parents toward their child could contribute to the development of schizophrenia. Therefore, while cognitive theories help us understand how schizophrenia manifests, they do not fully explain its origins, highlighting the need for more comprehensive models that integrate both cognitive and environmental factors.

Question 34

treatments: family therapy

Answer 34

NICE recommends all people with schizophrenia should be offered family therapy who are still in contact with family members. Family therapy is offered for 3-12 months and aims to reduce levels of expressed emotion within the family. garety estimates the relapse rate who receive family therapy is 25% compared to 50% who just receive standard care alone. Strategies used in family therapy: Psychoeducation: helping the family to better understand the condition forming an alliance: building trust between therapist and family reducing the emotional climate: and reducing stress and the burden of care for family members. Enhancing: creating the family's ability to anticipate and solve problems. reducing: reducing anger and guilt between family maintaining: and ensuring reasonable expectations between the family. encourage: setting appropriate limits, and maintaining a degree of separation.

Question 35

treatments: family therapy evaluation

Answer 35

Family therapy can be an effective approach to improving clinical outcomes in patients with mental health conditions. Pharaoh's study found that family therapy helps improve the patient's mental state, increases compliance with medication, and reduces relapse rates. This suggests that involving family members in the therapeutic process can provide emotional support and foster a more consistent approach to managing the patient's condition. When family members are educated about the illness, they can encourage medication adherence and offer practical help, which in turn can prevent relapses and stabilize mental health. Therefore, incorporating family therapy into treatment plans may be a valuable tool in improving both mental functioning and overall treatment success for patients. Family therapy interventions that support relatives can positively impact family dynamics and problem-solving. Lobban analyzed 50 family therapy studies and found that 60% of the interventions had a significant positive impact on problem-solving skills, family functioning, and relationship quality. This suggests that involving relatives in therapy can lead to improved communication and problem-solving within the family, which can, in turn, support the patient’s recovery. However, the studies’ poor methodological quality makes it challenging to clearly determine which interventions are most effective. Therefore, while the results are promising, further high-quality research is needed to accurately assess the effectiveness of these family therapy interventions.

Question 36

treatments: CBT

Answer 36

CBT tries to get the patient to identify and correct their fault interpretations. NICE recommend at least 16 sessions for the treatment of schizophrenia, which can be delivered in groups, but is usually 1-1. the aim is for people to establish links between their thoughts, feelings, or behaviours with respect to their general level of functioning. patients are encouraged to trace back to the origins of their symptoms in order to understand how they might have developed.

Question 37

treatments: CBT phases

Answer 37

Assessment: The patient talks about their experiences to the therapist. Using the patient's distress, realistic goals are created as a motivation for change. Engagement: the therapist empathises with the patient's perspective and their feelings of distress. ABC model: The patient will explain activating events that appear to cause their emotional and behavioural consequences. Normalisation: the patient is told the information to normalise the hallucinations and delusions they face. By telling them many people experience the same thing, they may feel less stigmatised and isolated. Critical Collaborative Analysis: the therapist uses gentle questioning to help the patient understand illogical deductions and conclusions. For example "If your voices are real, why can't I hear them?" Developing alternative: the patient will develop their alternative explanations for their unhealthy views.

Question 38

treatments: CBT evaluation

Answer 38

Despite NICE recommending CBTp as an effective treatment for schizophrenia, its availability and uptake remain limited, with only a small percentage of eligible patients receiving the treatment. A survey conducted by Haddock in the North West of England found that out of 187 randomly selected patients diagnosed with schizophrenia, only 13 were offered CBTp as a treatment. This stark discrepancy highlights a significant gap between clinical recommendations and actual practice. Although CBT is effective in improving outcomes for those with schizophrenia, many patients are not being allowed to benefit from it. This underlines the need for improved access to CBTp for individuals with schizophrenia, as well as better implementation of treatment guidelines to ensure that those who could benefit most are not left without this valuable intervention. CBTp is effective in treating schizophrenia, particularly in reducing re-hospitalization rates and improving symptom severity. NICE reviewed treatments for schizophrenia and found consistent evidence that CBTp reduces re-hospitalization rates up to 18 months after treatment compared to standard care. It also reduces symptom severity and may improve social functioning. These findings suggest that CBTp offers significant benefits for patients with schizophrenia, improving both their long-term stability and their ability to function socially. This makes CBTp a valuable treatment option alongside standard care. However, much of the research on CBTp has been conducted with patients who are also receiving standard care, This makes it difficult to isolate the effects of CBTp independently from the benefits of medication, suggesting that further research is needed to evaluate the therapy in isolation.

Question 39

Token Economy and the management of schizophrenia

Answer 39

This is a form of behavioural therapy where clinicians set target behaviours that they believe will improve the patient's engagement in daily activities. Target behaviours may include the patient brushing their hair/teeth. Tokens are awarded when a target behaviour is done, which can then be traded for rewards/privileges. Ayllon and Azrin used a token economy on a ward for females with schizophrenia. They were given a token with 'one gift' written on them once they had met a target behaviour such as making their beds. The tokens were then exchanged for privileges such as watching a film. The researchers found that the use of token economy with these women dramatically increased the number of desirable behaviours that the patient performed each day.

Question 40

Token Economy and the management of schizophrenia evaluation

Answer 40

Research by Dickerson supports the use of token economies as a treatment for schizophrenia, showing positive effects on adaptive behaviour. Dickerson reviewed 13 studies that implemented token economy systems for schizophrenia treatment and found that 11 of these studies reported beneficial effects linked to token economies. This suggests that token economies can help improve adaptive behaviours in individuals with schizophrenia, offering valuable evidence for their use in psychiatric settings. However, the studies reviewed were not without their flaws, which may affect the strength and generalizability of the findings. The methodological issues highlighted in these studies indicate that while token economies may have promise, further research with more robust designs is needed to fully validate their effectiveness and ensure reliable outcomes for patients. Token economies have limited effectiveness outside of hospital settings, particularly for patients living in the community. Corrigan noted that administering token economies to community patients is challenging because they only receive treatment for a few hours each day, unlike inpatients who are monitored by staff 24/7. As a result, the rewards system can only be applied during treatment hours. This limitation suggests that token economies may not have the same long-term impact when patients are outside the controlled environment of a hospital. The inconsistent application of the system in the community may reduce its overall effectiveness in maintaining behaviour change. Therefore, while token economies may show positive results in hospital settings, their effectiveness in real-world, community-based treatment is questionable, highlighting the need for alternative approaches to support patients once they leave institutional care.

Question 41

An interactionist approach: the diathesis-stress model: diathesis

Answer 41

Schizophrenia has a genetic component in terms of vulnerability. Evidence for this comes from twin studies that have found that if one identical twin has schizophrenia, there is a much higher chance of the other twin developing it, compared to other non-identical twins, such as brother and sister. However, this is not a 100% concordance rate, therefore this discordance among identical twins points to the fact that environment must play a role in determining whether biological predisposition leads to the disorder.

Question 42

An interactionist approach: the diathesis stress model: stress

Answer 42

The stressful life events that can trigger schizophrenia can vary from experiencing childhood trauma to living a highly urbanised environment. Varese found that children who experienced severe trauma before 16 were 3x more likely to develop schizophrenia in later life compared to the general population.

Question 43

An interactionist approach: the diathesis stress model: Tienari et al

Answer 43

Hospital records were reviewed of nearly 20,000 women who were admitted to a psychiatric hospital between 1960-1979. They identified those who had been diagnosed at least once with schizophrenia or paranoia. The list was checked to find those mothers who had one or more of their children adopted. The resulting sample of 145 adopted children was then matched a control group who did not have the genetic risk. Both groups of adoptees were independent assessed after a median interval of 12 years, and a follow up after 21 years. Of the 303 adoptees, 14 had developed schizophrenia over the course of the study. Out of these 14, 11 were from the high risk group. However, being reared in a ‘healthy’ adoptive family appeared to have a protective effect for those at high genetic risk.

Question 44

An interactionist approach: the diathesis-stress model: evaluation

Answer 44

Tienari et al identified several limitations in their study, particularly in how they assessed adoptive family functioning. One significant limitation was the use of the OPAS scale to assess family stress at a single point in time. This approach fails to account for the developmental changes in family functioning that can occur over time. By only measuring stress at one moment, the study overlooks how family dynamics may evolve as they adapt to adoption. Additionally, the study acknowledged the difficulty in distinguishing the source of stress between the adoptive family and the adoptee, given the reciprocal interactions between them. Therefore, the study’s methods do not fully capture the complexity of adoptive family functioning, which could impact the conclusions drawn about the role of family stress in adoption outcomes. Tarrier conducted a study to investigate the effects of different treatment combinations on patients with mental health issues. In the study, 315 patients were randomly assigned to one of three groups: a medication and CBT group, a medication and counseling group, and a control group. The results showed that patients in the combination group had lower symptom levels compared to the other groups. This suggests that the combination of medication and CBT might be more effective at reducing symptoms than either treatment alone. However, despite the improvement in symptom levels, there was no significant difference in hospitalisation rates between the groups. These findings indicate that while combined treatments may help reduce symptoms, they do not necessarily lead to fewer hospital admissions, suggesting that factors beyond symptom reduction may influence the need for hospitalization.